Reata Pharmaceuticals (NASDAQ: RETA)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Reata Pharmaceuticals (NASDAQ: RETA) through any online brokerage.
The latest price target for Reata Pharmaceuticals (NASDAQ: RETA) was reported by Citigroup on Friday, May 27, 2022. The analyst firm set a price target for 46.00 expecting RETA to rise to within 12 months (a possible 28.85% upside). 9 analyst firms have reported ratings in the last year.
The stock price for Reata Pharmaceuticals (NASDAQ: RETA) is $35.7 last updated August 5, 2022, 8:00 PM UTC.
There are no upcoming dividends for Reata Pharmaceuticals.
Reata Pharmaceuticals’s Q3 earnings are confirmed for Monday, November 7, 2022.
There is no upcoming split for Reata Pharmaceuticals.
Reata Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.